RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis. It offers robotic bench-top workstation for nucleic acid purification under the MagCore Plus II and Giga Automated Nucleic Acid Extractor names; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment. The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. It has operations in Taiwan, rest of Asia, Africa, the United States, and internationally. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.
Frequently asked questions
What sector does RBC Bioscience Corporation (6848) operate in?
RBC Bioscience Corporation belongs to the Other sector and operates in the Biotechnology industry.
What is RBC Bioscience Corporation (6848) current stock price?
As of the latest data, RBC Bioscience Corporation stock price is NT$21.60, with a previous close of NT$21.60.
What is RBC Bioscience Corporation (6848) current market capitalization?
RBC Bioscience Corporation market cap is approximately 308.30 million.
What is RBC Bioscience Corporation (6848) Earnings Per Share (EPS)?
The trailing EPS is NT$1.64.
What is RBC Bioscience Corporation (6848) Price-to-Earnings (P/E) ratio?
RBC Bioscience Corporation current P/E ratio is 13.17.
Does RBC Bioscience Corporation (6848) pay dividends?
Yes. RBC Bioscience Corporation pays annual dividends with an annualized yield of 5.56% and an estimated annual payout of NT$1.20 per share.
When is the next ex-dividend date for RBC Bioscience Corporation (6848)?
The next ex-dividend date is scheduled for July 09, 2027.
What is RBC Bioscience Corporation (6848) beta (volatility) score?
RBC Bioscience Corporation has a beta of 0.404, indicating lower volatility than the overall market.
